Explore Our Publications
Entrada’s commitment to publications & transparency
Entrada is committed to publishing the results of our sponsored research in a transparent, scientifically accurate, and timely manner. Entrada will apply high ethical standards to our publications and presentations and will adhere to recognized industry guidance such as International Committee of Medical Journal Editors (ICMJE) Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals and International Society for Medical Publication Professionals (ISMPP) Good Publication Practice for Communicating Company Sponsored Medical Research.
Past Manuscripts
-
Understanding Cell Penetration of Cyclic Peptides
- By: Dougherty, P., Sahni, A., Pei, D.
- In: Chem. Rev.
- On: December 1, 2019
Read OnlineDecember 1, 2019 -
Enhancing the Cell-Permeability of Stapled Peptides with a Cyclic Cell-Penetrating Peptide
- By: Dougherty, P., Wen, J., Pan, X., Koley, A., Ren, J., Sahni, A., Basu, R., Salim, H., Appiah Kubi, G., Qian, Z., Pei, D.
- In: J. Med. Chem.
- On: October 28, 2019
Read OnlineOctober 28, 2019 -
Development of a Cell-Permeable Cyclic Peptidyl Inhibitor Against the Keap1-Nrf2 Interaction
- By: Salim, H., Song, J., Sahni, A., Pei, D.
- In: J. Org. Chem.
- On: October 14, 2019
Read OnlineOctober 14, 2019 -
Cyclic Cell-Penetrating Peptides with Single Hydrophobic Groups
- By: Song, J., Qian, Z., Sahni, A., Chen, K., Pei, D.
- In: ChemBioChem
- On: July 12, 2019
Read OnlineJuly 12, 2019 -
Non-Peptidic Cell-Penetrating Motifs for Mitochondrion-Specific Cargo Delivery
- By: Appiah Kubi, G., Qian, Z., Amiar, S., Sahni, A., Stahelin, R.V., Pei, D.
- In: Angew. Chem. Int. Ed.
- On: December 4, 2018
Read OnlineDecember 4, 2018 -
Cell-Permeable Bicyclic Peptidyl Inhibitors Against NEMO-IκB Kinase Interaction Directly From a Combinatorial Library
- By: Rhodes, C., Dougherty, P., Cooper, J., Qian, Z., Lindert, S., Wang, Q., Pei, D.
- In: J. Am. Chem. Soc.
- On: September 3, 2018
Read OnlineSeptember 3, 2018